{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "frun (generic function with 1 method)"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Todo: \n",
    "#   Make some txs bad, and have trials weed these out\n",
    "#   Generalize srun to use an iteration fn\n",
    "#   There's some sort of bug where the trial is transitioned/closed multiple times. \n",
    "#   Base p23 n on p1-based power calculation (https://clincalc.com/stats/samplesize.aspx)\n",
    "#   Model decision making agents -- hypers go with d.m. agents\n",
    "#   At present, a pt can be treated with many drugs, including any number of drugs for the very same varient!\n",
    "#       This leads to over-the-top improvments, although it's not entirely obvious that this isn't \n",
    "#       a perfectly plausible strategy (cf. the 9-component GBM treatment), esp. before particular \n",
    "#       precision treatments haven't been approved. There are several things we're ignoring, specifically\n",
    "#       combined toxicity and drug interactions.\n",
    "#   There's a bug where because of the order of ops, the pts can end up with health << 0 just before death\n",
    "#   Allow \"cures\" (at present you only accrue variants, never lose them!) Maybe when healh == 1.0, clear varvac?\n",
    "#   Maybe txs should stop having an effect; possibly bcs the disease mutates away from the target variant\n",
    "#       to a new biomarker configuration. At present this makes no difference bcs we are assuming that we \n",
    "#       test on every cycle and treat to the results of the test (i.e., we \"chase\" the biomarkers). \n",
    "#       But more correctly we would treat with the same drug until it stops working.\n",
    "\n",
    "using Random\n",
    "using Distributions\n",
    "using Printf\n",
    "using CPUTime\n",
    "using PyPlot; const plt = PyPlot\n",
    "\n",
    "global gloglevel = 0\n",
    "function log!(msg,lvl=0) \n",
    "    lvl >= gloglevel ? print(msg) : false\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Globals and Hyperparmaters:\n",
    "##########################################################################################\n",
    "\n",
    "# Values declared as hypers are stored in the ghyps dictionary. This makes it convenient to\n",
    "# save them with run results, but makes access very slow, so use lets to pull them into local around\n",
    "# inner loops. Each entry in the dict is a pair: [current_value, default_value]. In initialization \n",
    "# we call sethyps() to set the current values to either defaiults, or to user-given values.\n",
    "\n",
    "# ******************************************************************************\n",
    "# *** WARNING: Computed hyperparams need to be computed and set in sethyps() ***\n",
    "# *** Any settings here of computed hyper paremeters are placeholders to     ***\n",
    "# *** show the sort of thing that these hyps are.                            ***\n",
    "# ******************************************************************************\n",
    "\n",
    "global ghyps = Dict()\n",
    "\n",
    "macro hyp(variable, value); ghyps[:($variable)] = [eval(:($value)),eval(:($value))]; end\n",
    "macro hyp(variable); :(ghyps[($variable)][1]); end # You have to use :symbols to make this work\n",
    "\n",
    "showhyps() = for (hyp, cd) in ghyps; @printf(\"%s=%s (default=%s)\\n\", hyp, cd[1], cd[2]) ; end\n",
    "\n",
    "@hyp npts 30\n",
    "@hyp nvs 10 # n variants describing a patient\n",
    "@hyp nyears 50\n",
    "\n",
    "# Turning this off will circumvent the trial process and go straight to expanded access.\n",
    "@hyp trialsp true\n",
    "\n",
    "# Only treat when you get below this level (FFF This should have measurement error!)\n",
    "@hyp htxthresh 0.7\n",
    "\n",
    "# Hypers for positive and negative effect sizes:\n",
    "@hyp espm 0.5\n",
    "@hyp espd 0.1\n",
    "@hyp esnm -0.1\n",
    "@hyp esnd  0.1\n",
    "\n",
    "# Simplified Beta Hyper Parameters [alpha,beta]\n",
    "@hyp hsbhps Dict(:farleftpeak => [1.5,20], :leftpeak => [3,11], :centered => [10,10], :rightpeak => [11,3])\n",
    "\n",
    "# Get a mean and deviation (usually for normal sampling) centered at the keyed beta, and with the keyed deviation\n",
    "BBMD(Mkey,Dkey) = rand(Beta(@hyp(:hsbhps)[Mkey][1],@hyp(:hsbhps)[Dkey][2])) # BetaBasedMandD\n",
    "\n",
    "# Variant occurrance dist (when sampled N>0.5)\n",
    "# ??? Is this too meta? Could just take means from hyper consts rather than sampling them from betas.\n",
    "@hyp hvopds [Normal(BBMD(:farleftpeak,:centered),BBMD(:leftpeak,:centered)) for i in 1:@hyp(:nvs)]\n",
    "\n",
    "@hyp vmm1m 0.05\n",
    "@hyp vmm1d 0.01\n",
    "@hyp vmm2m 0.20\n",
    "@hyp vmm2d 0.10\n",
    "@hyp vmm1w 0.95\n",
    "@hyp vmm2w 0.05\n",
    "@hyp vmm_effects_dev 0.1 # Deviation for N effect sizes centered on mixture model samples (FFF??? Sample this too?)\n",
    "\n",
    "# Variant effect size (ves) is sampled from a bimodal mixture\n",
    "@hyp vmm MixtureModel(Normal[Normal(0.05, 0.01),Normal(0.2, 0.1)],[0.95,0.05]) # Will be recomputed in init\n",
    "@hyp vesds [Normal(rand(@hyp(:vmm)),@hyp(:vmm_effects_dev)) for i in 1:@hyp(:nvs)] # Will be recomputed in init\n",
    "\n",
    "function printvesds()\n",
    "    log!(\"Variant effect size distributions:\\n\")\n",
    "    for vesd in @hyp(:vesds)\n",
    "        log!(@sprintf(\"%s\\n\",vesd))\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Structs, Global stores, Creators, and Printers\n",
    "##########################################################################################\n",
    "\n",
    "# Pateints are described by binary variant vectors, beginning at [0,...,0] and collecting variants at\n",
    "# the rate given by the variant occurrance probability (vop, per year==cycle). Each variant\n",
    "# also has an effect size (ves), which actually the mean and sd of the gaussian effect size, again, per year. \n",
    "# So, as patients develop variants over time, their health, which begins at 1.0, starts declining in accord\n",
    "# with collected variants. The trial could concienvably be a multie-tx field, but at the moment off-trial \n",
    "# treatments are one-shot and dependent on immediate variant tests, so we don't need to record txs other \n",
    "# than trials. The trial will be false if there's no trial.\n",
    "\n",
    "mutable struct pt; id; health; varvec; history; trial; trial_cycles end\n",
    "global gpts = []\n",
    "ptfmt(pt) = @sprintf(\"{Pt#%2d=%.2f%s{%s}}\",pt.id,pt.health,pt.varvec,ctfmt(pt.trial))\n",
    "\n",
    "# A treatment (tx) is just the target variant (by index), an set of effect size distributions (normals), \n",
    "# and an approval status, which is either true, for an approved tx, false for a failed on, or \n",
    "# a clinical trial structure. We create a new targted tx is based on when the number of patients \n",
    "# to die with a particular variant reaches > some % of the population.\n",
    "# The status will either be a trial, or true if it's approved\n",
    "# Effect model (em): [[variant number, effect distrubution]...]\n",
    "mutable struct tx; id; em; status; end\n",
    "global gtxs = []\n",
    "emfmt(em) = string(map(m->@sprintf(\"[%s,N%s]\",m[1],params(m[2])),em))\n",
    "txfmt(tx) = @sprintf(\"<Tx#%2d(%s):%s>\",tx.id,ctshortfmt(tx.status),emfmt(tx.em))\n",
    "\n",
    "# Clinical trials go trough 2 phases: 1 and 2/3 (23). The first phase seeks to power the second phase. When a new \n",
    "# drug is invented, it goes into a phase 1 trials, and can NOT be used except in the trial. Once it \n",
    "# passes phase 1 (if it does), it goes into a specifically-powered phase 23 trial. At THAT point, anyone\n",
    "# can use the drug. Patients who are enrolled in either a phase 1 or phase 2 trial only get the trial\n",
    "# treatment, whereas patients who are NOT in a trial can get any drug that is in phase 2 or beyond. \n",
    "# So an advantage of going into a phase 1 trials is that you get drug before anyone else. The disadvantage\n",
    "# is that you're stuck with that one drug. One question is, why would anyone who could get the drug anyway,\n",
    "# bother going into a phase 2/3 trial? The answer is that they wouldn't, but that's not the world we live in.\n",
    "# So there is another factor, which is that any patient who CAN go into a trial MUST go into a trial (under the\n",
    "# :strict policy). In :strict there is a health cutoff for the trial, which is based on the phase 1 analysis.\n",
    "# Any patient with the target mutation who passes the health cutoff MUST (under :strict) go into the 23 trial.\n",
    "# The :strict policy is actually more like the real world, and it's probably the comparison case. The other\n",
    "# policy (:open), any can get any drug that has passes phase 1, and so there's no reason that anyone would \n",
    "# go into a phase 23 trial, when they can just get tested all the time, and get whatever drug they want, and\n",
    "# any number of them, and change all the time. In fact, :open is to obviously better than :strict, and so not-\n",
    "# the-way-the-world-really-is, that I haven't even bother to implement :open!\n",
    "\n",
    "@hyp phase1_ptsneeded 3 # This looks like it shouldn't be a constant, but in practice, it actually is!\n",
    "@hyp phase1_duration_per_patient 3 # FFF ??? Maybe go to dose escalation, or patient response\n",
    "@hyp phase23_ptsneeded 3 # FFF Compute from Phase 1 results, see: https://clincalc.com/stats/samplesize.aspx\n",
    "@hyp phase23_duration_per_patient 3 # FFF Ditto should be computed based on phase 1, although less critical than n\n",
    "mutable struct ct; id; txs; pts; phase; ptsneeded; duration_per_patient; end\n",
    "global gcts = []\n",
    "ctfmt(ct) = @sprintf(\"[CT%2dph%d,n=%s]\",ct.id,ct.phase,length(ct.pts))\n",
    "ctfmt(status::Bool) = status\n",
    "ctshortfmt(status::Bool) = status\n",
    "ctshortfmt(ct) = @sprintf(\"[CT%2dp%d]\",ct.id,ct.phase)\n",
    "# ??? I tried this with nested maps but it didn't work.\n",
    "report() = for (obs,fmtfn) in ((gpts, ptfmt),(gtxs,txfmt),(gcts,ctfmt)); map(ob->@printf(\"%s\\n\",fmtfn(ob)),obs); end\n",
    "# Once phase 1 trials are completed, they get converted to phase23 and added to the phase23 list.\n",
    "global phase23_trials = []\n",
    "global completed_trials = [] \n",
    "\n",
    "##########################################################################################\n",
    "# Variants (biomarkers)\n",
    "##########################################################################################\n",
    "\n",
    "# Variants are accrued randomly throughout life. \n",
    "\n",
    "# Variant occurs? predicate (i.e., > 0.5) => true/false\n",
    "vop(vn) = (rand(@hyp(:hvopds)[vn]) > 0.5)\n",
    "\n",
    "# Maybe gain a variant (nvs just passed in for efficiency so we don't have to @hyp it)\n",
    "gainvars(varvec,nvs) = [((vop(vn) > 0.5) ? 1 : varvec[vn]) for vn in 1:nvs]\n",
    "\n",
    "# Patient health hit is the amount to reduce the pt's health based on the sum of samples\n",
    "# from all of the accrued variants. \n",
    "function varhealthhit(varvec)\n",
    "    let vesds = @hyp(:vesds)\n",
    "        #varhealthhit(varvec) = reduce(+,[varvec[vn]*rand(gvesds[vn]) for vn in 1:gnvs])\n",
    "        reduce(+,[varvec[vn]*rand(vesds[vn]) for vn in 1:@hyp(:nvs)])\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Treating and creating new treatments\n",
    "##########################################################################################\n",
    "@hyp txinventiondeathfraction 0.1\n",
    "@hyp hkilledthresh 999999.999999 # Gets init'ed in init() [Needs to be same type to avoid conv errs]\n",
    "@hyp hnewtxthresh 0.8\n",
    "\n",
    "# Each time a new treatment is created, it is intially created in the context of a clinical trial,\n",
    "# and as long as there is a trial for that treatment available, that's the preferred way to be treated.\n",
    "# In a phase 1 trials, it's the ONLY way you can get treated, but once the trial is in phase 2/3 (23)\n",
    "# anyone who is not in the trial's target model (meaning doesn't have the excluded variants), can get\n",
    "# the treatment, but patients in the trial MUST stay on the trial regimen, whereas others can get the tx\n",
    "# but aren't required to follow protocol if they end up not doing so well on the drug.\n",
    "\n",
    "function mcantxs() # maybe create a new treatment\n",
    "    # For each of the places where the counts of pts killed by particular variants > kill threshold\n",
    "    # decide whether to create a tx, and create it. (Note that there can be more than one tx/variant!)\n",
    "    let hkilledthresh = @hyp(:hkilledthresh), hnewtxthresh = @hyp(:hnewtxthresh) \n",
    "        killedpts = map(pt->pt.varvec,filter(pt->pt.health==0,gpts))\n",
    "        killedpts != [] ? killedpts = reduce(+,killedpts) : []\n",
    "        log!(@sprintf(\"Patient kill per variant counts: %s (hkilledthresh=%s)\\n\",killedpts, hkilledthresh))\n",
    "        for vn in (killedpts != [] ? findall(x->x>hkilledthresh,killedpts) : []) \n",
    "            if rand(Normal())>hnewtxthresh # FFF Adjust up for the number of txs for this var already on the market!\n",
    "                newtx(vn)\n",
    "            end\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "# Although each new tx is targeted to a particular variant, we also create side-effect\n",
    "# variant effects with a certain (small) probability. These are generally slightly negative,\n",
    "# whereas \n",
    "\n",
    "function newtx(vn)  # FFF Rationalize the effect size, and add a clinical trial in the status\n",
    "    # First is the main effect (generally +) and one side effect (-centered) FFF Makes these more flexible\n",
    "    # (Also, the main effect and side effect could cancel if they are the same vn -- prob disallow this! FFF UUU)\n",
    "    # Under one FFF theory, there should be a small side effect for EVERY vn -- too complex, maybe some day)\n",
    "    # A new tx gets a phase 1 trial for just this treatment. FFF trials can be started for multiple\n",
    "    # treatments through a different channel.\n",
    "    ntx=tx(1+length(gtxs),[[vn,Normal(@hyp(:espm),@hyp(:espd))],[rand(1:@hyp(:nvs)),Normal(@hyp(:esnm),@hyp(:esnd))]],\n",
    "        true) # Start out approved, and if you're going to run trials, this will get replaced with a phase 1 trial\n",
    "    if @hyp(:trialsp)\n",
    "        nct = ct(1+length(gcts),[ntx],[],1,@hyp(:phase1_ptsneeded),@hyp(:phase1_duration_per_patient))\n",
    "        ntx.status=nct\n",
    "        push!(gcts,nct)\n",
    "    end\n",
    "    push!(gtxs,ntx)\n",
    "    log!(@sprintf(\"Creating new tx: %s\\n\",txfmt(ntx)))\n",
    "end\n",
    "\n",
    "# When you treat a patient, you treat every variant for which he has a positive test\n",
    "# (tests are assumed to be correct! FFF: Probabalize tests!) If there are several possible\n",
    "# approved treatments for a a given variant, you choose one uniformly at random.\n",
    "\n",
    "function treat(pt)\n",
    "    # If the patient is on a trial, the treatment is determined by the trial, \n",
    "    # otherwise, you can treat per variants\n",
    "    ct = pt.trial\n",
    "    if ct == false\n",
    "        find_trial_or_freetreat(pt)\n",
    "    else\n",
    "        # Treat with the trail treatment, and then update the trial stats\n",
    "        log!(@sprintf(\"Treating pt#%s on trial %s\\n\",pt.id,ct.id))\n",
    "        treatwith(pt,ct.txs[1])\n",
    "        # If the pt has been on the trial the required number of cycles, take them off\n",
    "        if ct.duration_per_patient == pt.trial_cycles\n",
    "            log!(@sprintf(\"Taking pt#%s off trial %s\\n\",pt.id,ct.id))\n",
    "            # Nb. Taking a patient off a trial removes the trial from the patient record, but does not \n",
    "            # remove the patient from the TRIAL's record. We always remember which patients we treated on the trial\n",
    "            pt.trial = false\n",
    "            # Consider closing this trial if this is the last patient, and it's not already closed\n",
    "            # Patients can still be on the trial even though it's technically closed.\n",
    "            # No new ones can be recruited, but ones already on can be recruited.\n",
    "            if (length(ct.pts)==ct.ptsneeded)\n",
    "                # Okay, time to close the trial -- different logic for p1 and p23\n",
    "                if ct.phase == 1\n",
    "                    log!(@sprintf(\"Converting trial %s from phase 1 to phase 23\\n\",ct.id))\n",
    "                    push!(phase23_trials,ct)\n",
    "                    ct.phase = 23\n",
    "                    ct.ptsneeded = @hyp(:phase23_ptsneeded)\n",
    "                    # FFF !!! Compute from phase 1 variance: https://clincalc.com/stats/samplesize.aspx\n",
    "                    ct.duration_per_patient == @hyp(:phase23_duration_per_patient)\n",
    "                else\n",
    "                    log!(@sprintf(\"Trial %s has been completed, approving %s!\\n\",ct.id, ct.txs[1].id))\n",
    "                    push!(completed_trials,ct)\n",
    "                    ct.txs[1].status = true # Mark this treatment as approved!\n",
    "                end\n",
    "            end\n",
    "        else\n",
    "            pt.trial_cycles = pt.trial_cycles + 1\n",
    "        end\n",
    "    end\n",
    "end\n",
    "        \n",
    "function find_trial_or_freetreat(pt)\n",
    "    # The number of patients needed for a trial is used to decide whether a trial is available\n",
    "    # When phase 1 is done, the ptsneeeded will be reset to the appropriate number for p23, and will\n",
    "    # again count up. Once the p23 trial is completed, the ptsneeded will be full up, and won't get\n",
    "    # reset, so the trial will never be selected again.\n",
    "    goodtrials = filter(ct->(applicabletxp(ct.txs[1],pt.varvec)&&(length(ct.pts)<ct.ptsneeded)),gcts) \n",
    "    if goodtrials != []\n",
    "        ct = rand(goodtrials)\n",
    "        pt.trial = ct\n",
    "        pt.trial_cycles = 1\n",
    "        ct.pts=cat(ct.pts,pt,dims=1)\n",
    "        log!(@sprintf(\"Enrolled pt%s in trial %s\\n\",pt.id,ct.id))\n",
    "        treat(pt)\n",
    "    else\n",
    "        log!(@sprintf(\"Free Treating pt#%s\\n\",pt.id))\n",
    "        freetreat(pt)\n",
    "    end\n",
    "end\n",
    "        \n",
    "function applicabletxp(tx,varvec)\n",
    "    # The first elt of the vn array is the target\n",
    "    1==varvec[(map(vn_ves->vn_ves[1],tx.em))[1]]\n",
    "end\n",
    "\n",
    "# If we find a trial that this patient can go on, we do that, otherwise, we treat all the variants they have\n",
    "# The treatment either has to have no attached trials, or anh attached trial must be in phase23. The reason we\n",
    "# might get here even though there are trials for this vn, is that the available trials might be full up.\n",
    "\n",
    "function freetreat(pt)\n",
    "    for vn in findall(v->v==1,pt.varvec)\n",
    "        # Find all possible treatments for this variant:\n",
    "        # And then keep only those that aren't in a trial, or are in phase 23\n",
    "        txs = filter(tx->(tx.status==true)||(tx.status.phase==23),filter(tx->[]!=findall(vn_ves->vn_ves[1]==vn,tx.em),gtxs))\n",
    "        txs != [] ? treatwith(pt,txs[rand(1:end)]) : log!(@sprintf(\"No available treatments!\\n\"))\n",
    "    end\n",
    "end\n",
    "\n",
    "# Treating a patient entails applying an effect size (es) sample from each of the applicable \n",
    "# effect models in the tx. Each em is a pair of a variant number and an effect distribution for that\n",
    "# variant. Even though the variants are chosen to target one particular vn, all the vns that this pt\n",
    "# has will be applied! This models side effects. \n",
    "\n",
    "function treatwith(pt,tx)\n",
    "    log!(@sprintf(\"Treating pt#%s (%.2f) with %s\\n\",pt.id,pt.health,txfmt(tx)))\n",
    "    for (vn,ves) in tx.em\n",
    "        pt.varvec[vn]==1 ? pt.health=pt.health+rand(ves) : false # If this is a side effect, the dist will be negatively biased\n",
    "    end\n",
    "end\n",
    "\n",
    "\n",
    "##########################################################################################\n",
    "# Top Loop\n",
    "##########################################################################################\n",
    "\n",
    "function init(loglevel,overrides)\n",
    "    # Clear collectors\n",
    "    global gloglevel=loglevel\n",
    "    global gpts = [pt(p, 1.0, [0 for i in 1:@hyp(:nvs)], [1.0], false, nothing) for p in 1:@hyp(:npts)] # not on any trials to begin with\n",
    "    global gtxs = []\n",
    "    global gcts = []\n",
    "    global phase23_trials = []\n",
    "    sethyps(overrides)\n",
    "end\n",
    "\n",
    "function sethyps(overrides) # overrides is, e.g.: [:foo, 5.2], which will override the default\n",
    "    for (hyp, cd) in ghyps; cd[1]=cd[2]; end # First set everything to default\n",
    "    for (hyp, newval) in overrides; ghyps[hyp][1]=newval; end # Now override anything requested\n",
    "    # Now we have to compute computed hypers -- WWW Note that you can't override computed hypers \n",
    "    # bcs they get recomputed here! (Prob. should test for this and barf!)\n",
    "    ghyps[:hkilledthresh][1]=@hyp(:npts)*@hyp(:txinventiondeathfraction)\n",
    "    # Recompute variant effect bimodal mixture\n",
    "    ghyps[:vmm][1]=MixtureModel(Normal[Normal(@hyp(:vmm1m), @hyp(:vmm1d)),Normal(@hyp(:vmm2m),@hyp(:vmm2d))],\n",
    "                                [@hyp(:vmm1w),@hyp(:vmm2w)])\n",
    "    @hyp vesds [Normal(rand(@hyp(:vmm)),@hyp(:vmm_effects_dev)) for i in 1:@hyp(:nvs)] # Will be recomputed in init\n",
    "    # For efficiency this replicates the printlevel test to block the whole loop (much ado ...)\n",
    "    gloglevel <= 5 ? showhyps() : []\n",
    "end\n",
    "\n",
    "seevmm()=plt.hist(rand(@hyp(:vmm),1000),100)\n",
    "\n",
    "# Test shows lots of logging whereas run shows none, and averages the average mortalities over all runs.\n",
    "# You can override any hyperparameter on either with overrides=[[:hyp,newval],...]\n",
    "# ** Note that overrides, if you use them, have to be a list of lists, as: overrides=[[:foo,10],[:bar,20]]\n",
    "\n",
    "function test(;overrides=[],loglevel=0,plot=true) # Watch as variants accrue and health declines\n",
    "    init(loglevel,overrides)\n",
    "    log!(printvesds())\n",
    "    let nyears = @hyp(:nyears), htxthresh = @hyp(:htxthresh), nvs = @hyp(:nvs)\n",
    "        for year in 1:nyears\n",
    "            log!(@sprintf(\"\\n-------- %s --------\\n\",year))\n",
    "            for pt in gpts\n",
    "                # There's a sort of which-comes-first problem here about changing health level, then zero'ing it out\n",
    "                # if it's under 0, and then treating or not. Probably this logic could be simplified a bit FFF ???\n",
    "                pt.varvec=gainvars(pt.varvec,nvs)\n",
    "                (pt.health > 0) ? (pt.health=pt.health-varhealthhit(pt.varvec)) : false # Not sure why this syntax requires an else (:) ???\n",
    "                # (FFF Probably do this with tanh instead of these hard limits?)\n",
    "                (pt.health <= 0) ? (pt.health = 0) : (pt.health < htxthresh ? treat(pt) : false)\n",
    "                (pt.health >= 1.0) ? (pt.health = 1.0) : false \n",
    "                push!(pt.history,pt.health)\n",
    "            end\n",
    "            mcantxs()\n",
    "        # report()\n",
    "        end\n",
    "        if plot\n",
    "            plt.plot([[[pt.history for pt in gpts][i][j] for i in 1:ghyps[:npts][1]] for j in 1:nyears]) # UUU Array rotation\n",
    "            #plt.text(nyears-20,-0.2,\"maybe add a label?\")\n",
    "            plt.ylabel(\"Health\")\n",
    "            plt.xlabel(\"Years from Diagnosis\")\n",
    "            show(ghyps)\n",
    "        end\n",
    "        return mean(map(pt->((last(pt.history)!=0.0) ? nyears : (findall(h->h==0.0,pt.history)[1]) ),gpts))\n",
    "    end\n",
    "end\n",
    "\n",
    "function run(;n=10,overrides=[])\n",
    "    let a = []\n",
    "        for i in 1:n\n",
    "            r=test(loglevel=99,overrides=overrides,plot=false)\n",
    "            #@printf(\"%s:%s\\n\",i,r)\n",
    "            push!(a,r)\n",
    "        end\n",
    "        return [mean(a),std(a)]\n",
    "    end \n",
    "end\n",
    "#run(n=10,overrides=[[:htxthresh,0.7]])\n",
    "#test(overrides=[[:htxthresh,0.7]])\n",
    "\n",
    "# Scan Run (srun) scans a single hyp value. frun can do more complex scanning.\n",
    "# Examples:\n",
    "#srun(:txinventiondeathfraction,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "\n",
    "function srun(overkey,from,to,step;n=10,otheroverrides=[])\n",
    "    local results = []\n",
    "    let overrider = [[overkey,0.0]]\n",
    "        for val in from:step:to\n",
    "            overrider[1][2]=val\n",
    "            result = run(n=n,overrides=vcat(overrider,otheroverrides))\n",
    "            @printf(\"@%s=%s:%s\\n\",overkey,val,result)\n",
    "            push!(results,[val,result])\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in results], y=[x[2][1] for x in results]\n",
    "        plt.scatter(x,y) \n",
    "        plt.plot(x,y) \n",
    "        plt.errorbar(x, y, yerr=[(x[2][2]/sqrt(n)) for x in results])\n",
    "        plt.ylabel(\"Mean Survival\")\n",
    "        plt.xlabel(string(overkey))\n",
    "    end\n",
    "    return(results)\n",
    "end\n",
    "\n",
    "# This takes a generator structure and a terminator function. The generator\n",
    "# function looks like: [[:hyper,initval,#'nextfn(preval)],...] which are used\n",
    "# to set the initial value of the indicated hypers, and then increment it each\n",
    "# time around, and this continues until the terminator fn comes up true.\n",
    "# The first [1] entry in the overrider array is assumed to be the plotkey.\n",
    "# Termfn gets passed the overrider array. If can often just check the [1][2] value of that array.\n",
    "# Example: #frun([[:htxthresh,0.0,x->x+0.1]],array->array[1][2]>=1.0)\n",
    "\n",
    "function frun(genstruct,termfn;n=10,otheroverrides=[])\n",
    "    local results = []\n",
    "    let overrider = [[key,initval] for (key,initval,nextvalfn) in genstruct] \n",
    "        while !termfn(overrider)\n",
    "            result = run(n=n,overrides=vcat(overrider,otheroverrides))\n",
    "            @printf(\"@%s=%s:%s\\n\",overrider[1][1],overrider[1][2],result)\n",
    "            push!(results,[overrider[1][2],result])\n",
    "            for i in length(genstruct); overrider[i][2]=genstruct[i][3](overrider[i][2]); end\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in results], y=[x[2][1] for x in results]\n",
    "        plt.scatter(x,y) \n",
    "        plt.plot(x,y) \n",
    "        plt.errorbar(x, y, yerr=[(x[2][2]/sqrt(n)) for x in results])\n",
    "        plt.ylabel(\"Mean Survival\")\n",
    "        plt.xlabel(string(genstruct[1][1]))\n",
    "    end\n",
    "    return(results)\n",
    "end\n",
    "\n",
    "#frun([[:htxthresh,0.0,x->x+0.1]],array->array[1][2]>=1.0)\n",
    "\n",
    "#srun(:txinventiondeathfraction,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20)\n",
    "#srun(:htxthresh,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "@htxthresh=0.0:[7.140000000000001, 0.35199607180748665]\n",
      "@htxthresh=0.1:[7.44, 0.7459851386994878]\n",
      "@htxthresh=0.2:[7.863333333333332, 0.8719851057738075]\n",
      "@htxthresh=0.30000000000000004:[8.436666666666666, 0.9013638500203215]\n",
      "@htxthresh=0.4:[9.263333333333332, 1.0261338203587047]\n",
      "@htxthresh=0.5:[9.683333333333334, 1.1212041586758847]\n",
      "@htxthresh=0.6:[10.566666666666666, 1.4488820722402702]\n",
      "@htxthresh=0.7:[10.696666666666667, 1.6869469830011816]\n",
      "@htxthresh=0.7999999999999999:[12.176666666666666, 1.9811488125034802]\n",
      "@"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "Figure(PyObject <Figure size 640x480 with 1 Axes>)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "htxthresh=0.8999999999999999:[12.579999999999998, 1.7938991259471848]\n",
      "@htxthresh=0.9999999999999999:[11.676666666666668, 2.665465007030425]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "11-element Array{Any,1}:\n",
       " Any[0.0, [7.140000000000001, 0.35199607180748665]]\n",
       " Any[0.1, [7.44, 0.7459851386994878]]\n",
       " Any[0.2, [7.863333333333332, 0.8719851057738075]]\n",
       " Any[0.30000000000000004, [8.436666666666666, 0.9013638500203215]]\n",
       " Any[0.4, [9.263333333333332, 1.0261338203587047]]\n",
       " Any[0.5, [9.683333333333334, 1.1212041586758847]]\n",
       " Any[0.6, [10.566666666666666, 1.4488820722402702]]\n",
       " Any[0.7, [10.696666666666667, 1.6869469830011816]]\n",
       " Any[0.7999999999999999, [12.176666666666666, 1.9811488125034802]]\n",
       " Any[0.8999999999999999, [12.579999999999998, 1.7938991259471848]]\n",
       " Any[0.9999999999999999, [11.676666666666668, 2.665465007030425]]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "frun([[:htxthresh,0.0,x->x+0.1]],array->array[1][2]>=1.0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Julia 1.5.2",
   "language": "julia",
   "name": "julia-1.5"
  },
  "language_info": {
   "file_extension": ".jl",
   "mimetype": "application/julia",
   "name": "julia",
   "version": "1.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
